Clinical Trials Browser

Phase 2 × Stomach Neoplasms × Sorafenib × Clear all

NCT01187212 2020-01-07

Sorafenib Trial in Advanced and/or Recurrent Gastric Adenocarcinoma: Treatment Evaluation: STARGATE

Phase 2 Completed

Gastrointestinal

Stomach Neoplasms

NCT01158287 2014-12-31

Sorafenib. ICORG 06-41, V4

Phase 2 Completed

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Stomach Neoplasms

NCT00595985 2009-07-07

Sorafenib as a Second Line Treatment in Patients With Advanced or Metastatic Gastric Cancer

Phase 2 Terminated

Gastrointestinal

Stomach Neoplasms